News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Taiho Oncology Announces Positive Topline Results from Pivotal Phase 3 Trial of LONSURF® (trifluridine/tipiracil) in Metastatic Gastric Cancer

Here’s some positive news to kick off the weekend! A clinical trial of Lonsurf (trifluridine and tipiracil) plus supportive care improved overall survival for previously treated metastatic gastric cancer patients, compared to a placebo plus supportive care. The drug will now head to the FDA for consideration.

Read Source